T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 69 filers reported holding T2 BIOSYSTEMS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $52,000 | -16.1% | 19,807 | -3.1% | 0.00% | – |
| Q4 2018 | $62,000 | -59.7% | 20,449 | -0.8% | 0.00% | -100.0% |
| Q3 2018 | $154,000 | +19.4% | 20,606 | +23.7% | 0.00% | – |
| Q2 2018 | $129,000 | +174.5% | 16,653 | +85.3% | 0.00% | – |
| Q1 2017 | $47,000 | +6.8% | 8,987 | +7.0% | 0.00% | – |
| Q4 2016 | $44,000 | -99.9% | 8,402 | -0.3% | 0.00% | – |
| Q3 2016 | $60,990,000 | -8.1% | 8,424 | +0.1% | 0.00% | – |
| Q2 2016 | $66,371,000 | +25.2% | 8,412 | +55.1% | 0.00% | – |
| Q1 2016 | $53,000,000 | -10.2% | 5,422 | 0.0% | 0.00% | – |
| Q4 2015 | $59,000,000 | +125431.9% | 5,422 | +1.7% | 0.00% | – |
| Q3 2015 | $47,000 | -99.9% | 5,332 | +0.1% | 0.00% | – |
| Q2 2015 | $86,441,000 | +47.3% | 5,326 | +40.9% | 0.00% | – |
| Q1 2015 | $58,665,000 | -18.9% | 3,780 | +0.5% | 0.00% | – |
| Q4 2014 | $72,342,000 | – | 3,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,875,524 | $7,727,000 | 6.81% |
| Lagoda Investment Management, L.P. | 2,718,306 | $11,199,000 | 4.26% |
| TIGER MANAGEMENT L.L.C. | 2,321,800 | $9,566,000 | 1.49% |
| Senvest Management, LLC | 3,337,946 | $13,752,000 | 0.97% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 682,998 | $2,814,000 | 0.37% |
| Bell Rock Capital LLC | 137,850 | $564,000 | 0.30% |
| GAGNON SECURITIES LLC | 67,360 | $278,000 | 0.10% |
| Monashee Investment Management LLC | 18,248 | $75,000 | 0.03% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 409,502 | $1,687,000 | 0.02% |
| Alpine Global Management, LLC | 16,740 | $69,000 | 0.02% |